Miracle leaves that may help protect against liver damage

May 23, 2008

Sea buckthorn (Hippophae rhamnoides) berries are well known for their cholesterol busting properties, but scientists in India say that its leaves are also rich in anti-oxidants and may help ward off liver disease, according to new research due to be published in the Society of Chemical Industry's (SCI) Journal of the Science of Food and Agriculture.

Indigineous to the mountainous regions of China and Russia, sea buckthorn has been shown to be rich in vitamin C, vitamin E, flavonoids and essential fatty acids. The leaves are also used to make a tea.

In a clinically controlled study, scientists looked at whether the leaves had any protective effects by testing a group of rats, some of whom were given the leaf extract before being administered with a liver damage agent, carbon tetrachloride (CCI4).

Six groups were looked at in all - group 1 was given a daily dose of saline for 5 days; group 2 received saline for 4 days and on the 5th day was given CCI4; group 3 was given a daily dose of silymarin for 5 days followed by a single dose of CCI4; groups 4, 5 and 6 were given 50, 100 and 200mg of sea buckthorn leaf extract respectively for five days followed by a single dose of CCI4 on the 5th day.

The results showed that the leaf extract appeared to confer a protective mechanism on the liver - the rats given CCI4 minus the leaf extract had sustained significant liver damage compared to the control group that did not receive CCI4. In comparison, liver damage was severely restricted in the rats given leaf extract at 100mg and 200mg and CCI4.
-end-
For more information or a full copy of the paper, contact: Meral Nugent, Press and Public Relations Manager, T: +44 (0)20 7598 1533, F: +44 (0) 20 7598 1545, Mob: 07931 315077 E: meral.nugent@soci.org

Society of Chemical Industry

Related Liver Disease Articles from Brightsurf:

Fatty liver disease despite a normal weight
Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index.

Sobering reminder about liver disease
Alcohol's popularity and its central place in socialising in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Giant leap in diagnosing liver disease
A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients.

Link between liver and heart disease could lead to new therapeutics
A newly published study of flies found that protecting liver function also preserves heart health.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

Possible new treatment strategy for fatty liver disease
Researchers at Karolinska Institutet in Sweden have identified a molecular pathway that when silenced could restore the normal function of immune cells in people with fatty liver disease.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Fresh insights could lead to new treatments for liver disease
The fight against liver disease could be helped by the discovery of cells that cause liver scarring.

Better methods needed for predicting risk of liver disease
While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

Lab-on-a-chip may help identify new treatments for liver disease
Investigators have developed a 'lab on a chip' technology that can simulate different levels of non-alcoholic fatty liver disease progression.

Read More: Liver Disease News and Liver Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.